These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15578412)

  • 81. Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literature.
    Meini S; Laureano R; Fani L; Tascini C; Galano A; Antonelli A; Rossolini GM
    Infection; 2015 Dec; 43(6):777-81. PubMed ID: 26024568
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Bifidobacterium Bloodstream Infection in a Lymphoma Patient Undergoing Chemotherapy: A Case Study and Implications for Probiotic Use.
    Imataki O; Uemura M
    Am J Case Rep; 2024 Aug; 25():e944687. PubMed ID: 39180199
    [TBL] [Abstract][Full Text] [Related]  

  • 83.
    Kullar R; Goldstein EJC; Johnson S; McFarland LV
    Microorganisms; 2023 Mar; 11(4):. PubMed ID: 37110319
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The Potential Therapeutic Role of
    Guo H; Yu L; Tian F; Chen W; Zhai Q
    Foods; 2023 Feb; 12(4):. PubMed ID: 36832767
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Bacteraemia Caused by Probiotic Strains of
    Mikucka A; Deptuła A; Bogiel T; Chmielarczyk A; Nurczyńska E; Gospodarek-Komkowska E
    Pathogens; 2022 Aug; 11(9):. PubMed ID: 36145409
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Targeting gut microbiota as a possible therapy for mastitis.
    Hu X; Li S; Fu Y; Zhang N
    Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1409-1423. PubMed ID: 31079312
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Are Probiotic Really Safe for Humans?
    Zawistowska-Rojek A; Tyski S
    Pol J Microbiol; 2018; 67(3):251-258. PubMed ID: 30451441
    [TBL] [Abstract][Full Text] [Related]  

  • 88.
    Banna GL; Torino F; Marletta F; Santagati M; Salemi R; Cannarozzo E; Falzone L; Ferraù F; Libra M
    Front Pharmacol; 2017; 8():603. PubMed ID: 28919861
    [TBL] [Abstract][Full Text] [Related]  

  • 89. In silico analysis of protein toxin and bacteriocins from Lactobacillus paracasei SD1 genome and available online databases.
    Surachat K; Sangket U; Deachamag P; Chotigeat W
    PLoS One; 2017; 12(8):e0183548. PubMed ID: 28837656
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement system.
    Nissilä E; Douillard FP; Ritari J; Paulin L; Järvinen HM; Rasinkangas P; Haapasalo K; Meri S; Jarva H; de Vos WM
    PLoS One; 2017; 12(5):e0176739. PubMed ID: 28493885
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia.
    Aroutcheva A; Auclair J; Frappier M; Millette M; Lolans K; de Montigny D; Carrière S; Sokalski S; Trick WE; Weinstein RA
    Probiotics Antimicrob Proteins; 2016 Mar; 8(1):31-40. PubMed ID: 26915093
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Risk and safety of probiotics.
    Doron S; Snydman DR
    Clin Infect Dis; 2015 May; 60 Suppl 2(Suppl 2):S129-34. PubMed ID: 25922398
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Towards a better understanding of Lactobacillus rhamnosus GG--host interactions.
    Segers ME; Lebeer S
    Microb Cell Fact; 2014 Aug; 13 Suppl 1(Suppl 1):S7. PubMed ID: 25186587
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Lactobacillus rhamnosus bacteremia: an emerging clinical entity.
    Gouriet F; Million M; Henri M; Fournier PE; Raoult D
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2469-80. PubMed ID: 22544343
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Antimicrobial susceptibility of human blood culture isolates of Lactobacillus spp.
    Danielsen M; Wind A; Leisner JJ; Arpi M
    Eur J Clin Microbiol Infect Dis; 2007 Apr; 26(4):287-9. PubMed ID: 17318478
    [No Abstract]   [Full Text] [Related]  

  • 96. Intraspecific genotypic characterization of Lactobacillus rhamnosus strains intended for probiotic use and isolates of human origin.
    Vancanneyt M; Huys G; Lefebvre K; Vankerckhoven V; Goossens H; Swings J
    Appl Environ Microbiol; 2006 Aug; 72(8):5376-83. PubMed ID: 16885289
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood.
    Ouwehand AC; Saxelin M; Salminen S
    Clin Infect Dis; 2004 Dec; 39(12):1858-60. PubMed ID: 15578412
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland.
    Salminen MK; Tynkkynen S; Rautelin H; Saxelin M; Vaara M; Ruutu P; Sarna S; Valtonen V; Järvinen A
    Clin Infect Dis; 2002 Nov; 35(10):1155-60. PubMed ID: 12410474
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG.
    Salminen MK; Rautelin H; Tynkkynen S; Poussa T; Saxelin M; Valtonen V; Järvinen A
    Clin Infect Dis; 2004 Jan; 38(1):62-9. PubMed ID: 14679449
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.